An exploratory, randomized, double-blind, double-dummy, placebo- and active-controlled Phase II trial to evaluate the efficacy and safety of a topical application of GRT7019 in subjects with chronic pain due to knee osteoarthritis
Latest Information Update: 26 Jul 2018
Price :
$35 *
At a glance
- Drugs Diclofenac-hydroxyethylpyrrolidine/Lidocaine (Primary) ; Diclofenac; Lidocaine; Pantoprazole
- Indications Pain
- Focus Proof of concept; Therapeutic Use
- Sponsors Grunenthal
- 20 Jan 2018 Status changed from recruiting to completed.
- 11 May 2017 New trial record